Monoclonal antibodies (mAbs) directed against the spike of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …

Kidney transplant recipients (KTRs) show poorer response to SARS-CoV-2 mRNA
vaccination, yet response patterns and mechanistic drivers following third doses are ill …

Purpose of review: To review the data on the immunogenicity of COVID-19 vaccines,
administered by different strategies, in solid organ transplant recipients (SOTRs). Recent …

Modification of vaccination strategies is necessary to improve the immune response to
SARS‐CoV‐2 vaccination in kidney transplant recipients (KTRs). This multicenter …

A recent study concluded that SARS‐CoV‐2 mRNA vaccine responses were improved
among transplant patients taking mTOR inhibitors (mTORi). This could have profound …

Background The use of vaccination to prevent infection has a long history, starting in the
1700s with Jenner. New innovations have led to improvements in the safety and efficacy of …

Background Immunocompromised patients have an increased risk of developing severe
COVID disease, as well as a tendency to suboptimal responses to vaccines. The objective of …

Background. Solid organ transplant recipients (SOTRs) are less likely to mount an antibody
response to SARS-CoV-2 mRNA vaccines. Understanding risk factors for impaired vaccine …

Background Although mRNA vaccines have overall efficacy preventing morbidity/mortality
from SARS-CoV-2 infection, immunocompromised persons remain at risk. Antibodies mostly …

Lung transplant recipients (LTRs) are particularly at risk of developing severe coronavirus
disease-2019 (COVID-19), but are also difficult to protect by vaccination due to their …